Prospective Observational Real-Life Study (STRATEGE) Shows the Efficacy of Treat-to-Target Strategy and Methotrexate Monotherapy Optimization in Patients with Established Rheumatoid Arthritis

被引：0
|
作者：
Flipo, Rene-Marc [1 ]
Gaujoux-Viala, Cecile [2 ,3 ]
Hudry, Christophe [4 ,5 ]
Zinovieva, Elena [6 ]
Leutenegger, Eric [7 ]
Herman-Demars, Helene [6 ]
机构：
[1] Lille Univ Hosp Roger Salengro, Rheumatol Dept, Lille, France
[2] Univ Hosp Nimes, Rheumatol Dept, Nimes, France
[3] Montpellier Univ, EA2415, Nimes, France
[4] Cochin Hosp, Rheumatol, Paris, France
[5] Rheumatol Inst, F-75008 Paris, France
[6] Nord Pharma, Dept Med, Paris, France
[7] GECEM, Montrouge, France
来源：
ARTHRITIS & RHEUMATOLOGY | 2016年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
645
引用
收藏
页数：2
相关论文
共 50 条
  • [31] HIGHER LIKELIHOOD OF RESPONSE IN RHEUMATOID ARTHRITIS PATIENTS TREATED IN A REAL-LIFE SETTING WITH ADALIMUMAB IN COMBINATION WITH METHOTREXATE, BUT NOT WITH OTHER DMARDS, VERSUS ADALIMUMAB MONOTHERAPY
    Kiely, P.
    Florentinus, S.
    Keidel, S.
    Lacerda, A.
    Karunaratne, M.
    McCaskill, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 432 - 433
  • [32] TREAT TO TARGET MULTIAPPROACH MODEL IN A 3 YEAR FOLLOW-UP COHORT OF PATIENTS WITH RHEUMATOID ARTHRITIS. REAL-LIFE EFFECTIVENESS
    Santos-Moreno, Pedro
    Villarreal-Peralta, Laura
    Cabrera, Michael
    Buitrago-Garcia, Diana
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2019, 25 : S56 - S56
  • [33] EFFECTIVENESS OF CONVENTIONAL DMARD THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED UNDER A TREAT TO TARGET MODEL - LESSONS FROM A REAL-LIFE COHORT
    Santos-Moreno, P.
    Buitrago-Garcia, D.
    Villarreal, L.
    Cabrera, M.
    Castillo, E.
    Cardozo, E.
    Farietta, S.
    Giraldo, R.
    Gomez, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 982 - 983
  • [34] Sustained Effectiveness after Remission Induction with Methotrexate and Step-Down Glucocorticoids in Patients with Early Rheumatoid Arthritis Following a Treat-to-Target Strategy after 2 Years
    Stouten, Veerle
    Joly, Johan
    De Cock, Diederik
    Pazmino, Sofia
    Van der Elst, Kristien
    Westhovens, Rene
    Verschueren, Patrick
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [35] Prognostic Factors Toward Clinically Relevant Radiographic Progression in Patients With Rheumatoid Arthritis in Clinical Practice A Japanese Multicenter, Prospective Longitudinal Cohort Study for Achieving a Treat-to-Target Strategy
    Koga, Tomohiro
    Okada, Akitomo
    Fukuda, Takaaki
    Hidaka, Toshihiko
    Ishii, Tomonori
    Ueki, Yukitaka
    Kodera, Takao
    Nakashima, Munetoshi
    Takahashi, Yuichi
    Honda, Seiyo
    Horai, Yoshiro
    Watanabe, Ryu
    Okuno, Hiroshi
    Aramaki, Toshiyuki
    Izumiyama, Tomomasa
    Takai, Osamu
    Miyashita, Taiichiro
    Sato, Shuntaro
    Kawashiri, Shin-ya
    Iwamoto, Naoki
    Ichinose, Kunihiro
    Tamai, Mami
    Origuchi, Tomoki
    Nakamura, Hideki
    Aoyagi, Kiyoshi
    Eguchi, Katsumi
    Kawakami, Atsushi
    MEDICINE, 2016, 95 (17)
  • [36] Treat-to-target biologic therapy in patients with rheumatoid arthritis is more efficacious and safe compared to delayed initiation of biologics: a real-world study
    Lampropoulos, C. E.
    Orfanos, P.
    Manoussakis, M. N.
    Tzioufas, A. G.
    Moutsopoulos, H. M.
    Vlachoyiannopoulos, P. G.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2017, 35 (02) : 192 - 200
  • [37] Remission rate and predictors of remission in patients with rheumatoid arthritis under treat-to-target strategy in real-world studies: a systematic review and meta-analysis
    Yu, Chen
    Jin, Shangyi
    Wang, Yanhong
    Jiang, Nan
    Wu, Chanyuan
    Wang, Qian
    Tian, Xinping
    Li, Mengtao
    Zeng, Xiaofeng
    CLINICAL RHEUMATOLOGY, 2019, 38 (03) : 727 - 738
  • [38] Remission rate and predictors of remission in patients with rheumatoid arthritis under treat-to-target strategy in real-world studies: a systematic review and meta-analysis
    Chen Yu
    Shangyi Jin
    Yanhong Wang
    Nan Jiang
    Chanyuan Wu
    Qian Wang
    Xinping Tian
    Mengtao Li
    Xiaofeng Zeng
    Clinical Rheumatology, 2019, 38 : 727 - 738
  • [39] 12-month results from the real-life observational treat-to-target and tight-control therapy NOR-Gout study: achievements of the urate target levels and predictors of obtaining this target
    Uhlig, Till
    Karoliussen, Lars F.
    Sexton, Joseph
    Borgen, Tove
    Haavardsholm, Espen A.
    Kvien, Tore K.
    Hammer, Hilde Berner
    RMD OPEN, 2021, 7 (01):
  • [40] SUBCUTANEUOS (SC) METHOTREXATE (MTX) IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA) AS A PART OF "TREAT TO TARGET" (T2T) STRATEGY IN REAL PRACTICE: PRELIMINARY RESULTS OF REMARCA STUDY
    Karateev, D.
    Luchikhina, E.
    Gridneva, G.
    Muravyev, Y.
    Demidova, N.
    Lukina, G.
    Lopareva, E.
    Olyunin, Y.
    Nasonov, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 893 - 893
12345